Efficacy of Reslizumab in Patients with Poorly Controlled Eosinophilic Asthma: Subgroup Analysis of Patients with Nasal Polyps

Patients with poorly controlled asthma on high-dose inhaled corticosteroids and >=3% sputum eosinophils were randomized to reslizumab 3.0mg/kg or placebo at weeks 0, 4, 8, and 12.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2011-02, Vol.127 (2), p.AB84-AB84
Main Authors: Mathur, S, Castro, M, Hargreave, F, Xie, F, Wilkins, H.J, Henkel, T, Nair, P
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Medical research
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with poorly controlled asthma on high-dose inhaled corticosteroids and >=3% sputum eosinophils were randomized to reslizumab 3.0mg/kg or placebo at weeks 0, 4, 8, and 12.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2010.12.340